Showing results (51-60 of 533) with videos related to
Sort By:
Pageof 54
Blood|February 27, 2015
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Ramasamy Santhanam, et al.Current Opinion in Hematology|January 15, 2019
Progress in the problem of relapsed or refractory acute myeloid leukemiaAlice S Mims, William BlumInternational Journal of Occupational and Environmental Health|May 15, 2010
The unique developmental considerations of youth-related work injuriesMay Sudhinaraset, Robert William BlumHematology. American Society of Hematology. Education Program|January 18, 2011
Evidence-based mini-review: Should patients over the age of 60 with INT-2 or high-risk myelodysplastic syndrome undergo allogeneic stem cell transplantation prior to progression to acute myelogenous leukemia?Mark A Schroeder, William BlumBlood|November 4, 2010
The prognostic and functional role of microRNAs in acute myeloid leukemiaGuido Marcucci, Krzysztof Mrózek, Michael D Radmacher, et al.Leukemia & Lymphoma|December 22, 2012
Pharmacokinetics and dose escalation of the heat shock protein inhibitor 17-allyamino-17-demethoxygeldanamycin in combination with bortezomib in relapsed or refractory acute myeloid leukemiaAlison R Walker, Rebecca Klisovic, Jeffrey S Johnston, et al.British Journal of Clinical Pharmacology|January 24, 2019
Population pharmacokinetics of lenalidomide in patients with B-cell malignanciesJim H Hughes, Mitch A Phelps, Richard N Upton, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 28, 2006
Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomesShih-Jiuan Chiu, Shujun Liu, Danilo Perrotti, et al.Blood Reviews|August 22, 2018
The emerging story of acute lymphoblastic leukemia among the Latin American population - biological and clinical implicationsElisa Quiroz, Ibrahim Aldoss, Vinod Pullarkat, et al.Rapid Communications in Mass Spectrometry : RCM|April 3, 2003
Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the bloodJim J Xiao, John Byrd, Guido Marcucci, et al.Pageof 54